Private Equity Money Is Flowing Into Healthcare Again - What It Means for Independent Practices

Primary Care Perspective - Texas Edition | Wednesday, February 18, 2026

Strategic intelligence for independent primary care physicians in Texas.

Why This Landed on My Radar

Private equity had a strong year in healthcare dealmaking in 2025, and that’s not abstract Wall Street news - it directly affects how we compete for staff, what our referral partners look like, and whether we can negotiate decent payer contracts as independents. When PE money floods into our sector, the rules of the game change fast, and we need to understand what’s being bought and why.

Here’s What’s Going On

According to Modern Healthcare’s latest analysis with PitchBook data, private equity dealmaking in healthcare remained robust throughout 2025, despite some cooling in the final months of the year. While the article doesn’t break out specific dollar figures in the excerpt, the headline itself - “What’s hot, what’s not” - signals that PE firms are being selective, chasing certain healthcare sectors while pulling back from others.

This isn’t happening in a vacuum. We’ve watched PE consolidation accelerate across multiple healthcare verticals over the past few years - dermatology, ophthalmology, gastroenterology, anesthesiology, and emergency medicine have all seen significant roll-ups. These firms are betting that they can aggregate fragmented practices, extract operational efficiencies, negotiate better payer rates through scale, and ultimately generate returns for their investors. The strong 2025 activity suggests they’re still finding plenty of targets and that capital remains available despite broader economic uncertainty.

The late-year slowdown mentioned is worth noting. It could signal investor caution about regulatory changes, concerns about Medicare Advantage rate pressure, or simply natural market saturation in certain specialties. But “slowdown” doesn’t mean “stopped” - it means PE firms are being more strategic about where they deploy capital.

What This Means for Your Practice

Here in Texas, PE consolidation creates both pressure and opportunity for those of us staying independent. Let’s be clear-eyed about what we’re facing.

First, the competition for talent just got harder. When a PE-backed group opens down the street offering $40K signing bonuses and loan forgiveness packages we can’t match, recruiting gets brutal. They’re also hiring away experienced practice managers and coders by offering corporate salaries that blow past what a five-physician independent practice can afford. We’re competing against capital pools measured in hundreds of millions of dollars.

Second, our referral networks are getting complicated. That friendly gastroenterologist who always took your calls? His practice just got bought, and now there’s a “preferred referral network” you’re not part of. The orthopedic group that used to send you post-op follow-ups? They’re now owned by the same PE firm that bought the imaging center, and suddenly those referrals dried up because they’re building a vertically integrated system.

Third - and this is critical for Texas - payer negotiations get tougher when you’re at the table alone. A PE-backed group representing 50 physicians has leverage we don’t. BCBS Texas and United Healthcare, which dominate our commercial market, will absolutely play ball with larger entities while squeezing our reimbursement rates. We’re already operating on thin margins with the nation’s largest uninsured population affecting our payer mix, and without Medicaid expansion to fall back on, every percentage point of reimbursement matters.

But here’s what the PE playbook tells us: scale matters, operational efficiency matters, and data matters. They’re not magic - they’re systematizing what many of us do inconsistently. They’re implementing revenue cycle management systems that capture every billable service, they’re using technology to reduce administrative burden, and they’re making data-driven decisions about what services to offer and how to staff them.

The question isn’t whether to sell to PE - that’s a personal decision with implications I won’t pretend to advise on. The question is whether we can adopt some of what makes them attractive (operational discipline, technology leverage, strategic payer relationships) while maintaining our independence and physician-led model.

Key Takeaways

• PE consolidation in healthcare remained strong through 2025, creating increased competition for staff, shifts in referral patterns, and pressure on independent practices in payer negotiations
• Texas independents face unique challenges: largest uninsured population, no Medicaid expansion, and a commercial market dominated by two major payers who have more incentive to negotiate with larger groups
• The PE advantage isn’t mysterious - it’s operational systems, technology deployment, complete charge capture, and negotiating leverage through scale
• Staying competitive as an independent requires matching PE-backed practices on efficiency without selling your autonomy - better revenue cycle management, strategic technology adoption, and potentially forming your own practice coalitions for payer negotiations
• Those who wait to modernize operations will find themselves at a growing disadvantage as PE-backed competitors use their capital to offer better patient experience, recruit top talent, and squeeze independents on referrals

What Smart Practices Are Doing

The independent practices thriving in this environment aren’t trying to outspend PE-backed groups - they’re out-executing them on patient experience and operational efficiency. They’re investing in revenue cycle technology that captures charges as accurately as corporate systems, they’re forming independent practice associations to negotiate collectively with payers, and they’re using the flexibility of independence as a competitive advantage rather than pretending PE consolidation isn’t happening.

Source

What’s hot, what’s not in healthcare private equity dealmaking, Modern Healthcare

Primary Care Perspective delivers curated intelligence from trusted healthcare sources.

© 2026 Primary Care Perspective | Texas Edition